These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 18536615

  • 1. The effect of treatments given to patients before initiation of anti-vascular endothelial growth factor treatment.
    Hedaya J, Freeman WR.
    Retina; 2008 Jun; 28(6):911-2; author reply 912. PubMed ID: 18536615
    [No Abstract] [Full Text] [Related]

  • 2. The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).
    Derriman L, Marshall J, Moorman C, Downes SM.
    Retina; 2008 Jun; 28(6):910; author reply 910-1. PubMed ID: 18536613
    [No Abstract] [Full Text] [Related]

  • 3. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks.
    Rinaldi M, Dell'Omo R, Romano MR, Chiosi F, Cipollone U, Costagliola C.
    Arch Ophthalmol; 2007 Oct; 125(10):1422-3. PubMed ID: 17923555
    [No Abstract] [Full Text] [Related]

  • 4. Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum.
    Bhatnagar P, Freund KB, Spaide RF, Klancnik JM, Cooney MJ, Ho I, Fine HF, Yannuzzi LA.
    Retina; 2007 Sep; 27(7):897-902. PubMed ID: 17891014
    [Abstract] [Full Text] [Related]

  • 5. Choroidal neovascularization in angioid streaks and pseudoxanthoma elasticum: 1 year follow-up.
    Schiano Lomoriello D, Parravano MC, Chiaravalloti A, Varano M.
    Eur J Ophthalmol; 2009 Sep; 19(1):151-3. PubMed ID: 19123166
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.
    Teixeira A, Moraes N, Farah ME, Bonomo PP.
    Acta Ophthalmol Scand; 2006 Dec; 84(6):835-6. PubMed ID: 17083556
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Angioid streaks in pseudoxanthoma elasticum.
    Waqar M, Dhingra N.
    Postgrad Med J; 2019 Apr; 95(1122):220. PubMed ID: 30580324
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rapid progression of angioid streaks following intravitreal bevacizumab.
    Sen PR, Rishi P, Sen P, Rishi E, Shroff D.
    Can J Ophthalmol; 2009 Oct; 44(5):e39-40. PubMed ID: 19798813
    [No Abstract] [Full Text] [Related]

  • 17. Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.
    Spandau UH, Jonas JB.
    Acta Ophthalmol Scand; 2007 May; 85(3):340-1. PubMed ID: 17488467
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report.
    Karampelas M, Soumplis V, Karagiannis D, Parikakis E, Webster AR.
    BMC Res Notes; 2013 Dec 11; 6():530. PubMed ID: 24325973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.